Reticulon 3-mediated Chk2/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus.

MLA

Shushu Song, et al. “Reticulon 3-Mediated Chk2/P53 Activation Suppresses Hepatocellular Carcinogenesis and Is Blocked by Hepatitis B Virus.” Gut, vol. 70, no. 11, Nov. 2021, pp. 2159–71. EBSCOhost, https://doi.org/10.1136/gutjnl-2020-321386.

APA

Shushu Song, Yinghong Shi, Weicheng Wu, Hao Wu, Lei Chang, Peike Peng, Lei Zhang, Jia Fan, Jianxin Gu, & Yuanyuan Ruan. (2021). Reticulon 3-mediated Chk2/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut, 70(11), 2159–2171. https://doi.org/10.1136/gutjnl-2020-321386

Chicago

Shushu Song, Yinghong Shi, Weicheng Wu, Hao Wu, Lei Chang, Peike Peng, Lei Zhang, Jia Fan, Jianxin Gu, and Yuanyuan Ruan. 2021. “Reticulon 3-Mediated Chk2/P53 Activation Suppresses Hepatocellular Carcinogenesis and Is Blocked by Hepatitis B Virus.” Gut 70 (11): 2159–71. doi:10.1136/gutjnl-2020-321386.